drugset / Trial / NCT01358227
A Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the side effects and best weekly dose of PR104 in patients with advanced solid tumors.
Timeline
- Start
- 2006-12
- Primary completion
- 2009-12
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PR104 | Small molecule | — | Intravenous |